Zou Jing, Wang Zhen, Chen Yukun, Zhang Guoping, Chen Luguang, Lu Jianping
Department of Otolaryngology-Head and Neck Surgery, Center for Otolaryngology-Head & Neck Surgery of Chinese PLA, Changhai Hospital, Second Military Medical University, Shanghai, China.
Department of Radiology, Changhai Hospital, Second Military Medical University, Shanghai, China.
World J Otorhinolaryngol Head Neck Surg. 2020 Jan 3;5(4):180-187. doi: 10.1016/j.wjorl.2019.04.001. eCollection 2019 Dec.
Endolymphatic hydrops (EH) become visible in vertigo patients, particularly in those with Meniere's disease (MD), in vivo using gadolinium-enhanced MRI. However, the image quality is not satisfying after intravenous injection of gadolinium chelate (GdC), and occasional failure in GdC uptake has been noticed after traditional intratympanic injection. In the present report, targeted delivery of GdC and using a cost-effective MRI system to obtain high quality images of EH in only 8 min will be introduced.
39 MD patients were recruited in the study. First, 0.1 ml of 20-fold diluted gadolinium-diethylenetriamine acid (Gd-DTPA) was delivered onto the posterior upper part of the tympanic medial wall using a soft-tipped micro-irrigation catheter through an artificially perforated tympanic membrane. Inner ear MRI was performed 24 h after Gd-DTPA administration using a 3T MR machine and a 20-channel head/neck coil with an 8 min sequence of medium inversion time inversion recovery imaging with magnitude reconstruction (MIIRMR). The parameters were as follows: TR 16000 ms, TE 663 ms, inversion time 2700 ms, flip angle 180°, slices per slab 60.
Efficient inner ear uptake of Gd-DTPA was detected 24 h after delivery and it created excellent contrast in the inner ear of all cases. High quality images demonstrating EH in the vestibule and cochlea were obtained.
Targeted delivery of minimum Gd-DTPA (0.1 ml, 20-fold dilution) onto the posterior upper portion of the tympanic medial wall and MRI with MIIRMR in a 3T machine and 20-channel head/neck coil are clinically practical to obtain high quality images displaying EH.
使用钆增强磁共振成像(MRI)可在体内观察到眩晕患者,尤其是梅尼埃病(MD)患者的内淋巴积水(EH)情况。然而,静脉注射钆螯合物(GdC)后图像质量并不理想,且传统鼓室内注射后偶尔会出现GdC摄取失败的情况。在本报告中,将介绍靶向递送GdC并使用经济高效的MRI系统在仅8分钟内获取EH高质量图像的方法。
本研究招募了39例MD患者。首先,使用软头微灌流导管通过人工穿孔的鼓膜将0.1 ml 20倍稀释的钆二乙烯三胺五乙酸(Gd-DTPA)递送至鼓室内壁后上部。在给予Gd-DTPA 24小时后,使用3T MR机器和20通道头/颈线圈进行内耳MRI检查,采用8分钟的中等反转时间反转恢复成像并进行幅度重建(MIIRMR)序列。参数如下:重复时间(TR)16000 ms,回波时间(TE)663 ms,反转时间2700 ms,翻转角180°,每层切片60层。
给药24小时后检测到Gd-DTPA在内耳的有效摄取,且在所有病例的内耳中均产生了良好的对比度。获得了显示前庭和耳蜗内EH的高质量图像。
将最小剂量的Gd-DTPA(0.1 ml,20倍稀释)靶向递送至鼓室内壁后上部,并在3T机器和20通道头/颈线圈中采用MIIRMR进行MRI检查,在临床上切实可行,能够获得显示EH的高质量图像。